See Event Calendar Donate

Who We are?

Nucleate Israel is a vital component of the global Nucleate network, dedicated to fostering the next generation of biotech entrepreneurs. It focuses on bridging the gap between academic innovation and industry application by providing educational programs, mentorship, and networking opportunities. Through initiatives like the "Activator" program, Nucleate Israel empowers scientists and business students to translate groundbreaking research into viable biotech ventures, thus strengthening the Israeli biotech ecosystem and connecting it to the broader international community.

PARTICIPATING INSTITUTIONS

REGIONAL LEADERSHIP

Daniel Somekh

Daniel Somekh
Managing Director & Dir., Programs
Yael Tahan
Managing Director & Dir., Partnerships
Sarit Feldman
Dir., Communities
Ron Nagar
Dir., Finance
Shalhevet Klemfner
HUJI Lead
Elisheva Gur
HUJI Team
Naomi Tawil-Winter
HUJI Team
Elad Dvir
HUJI Team
Ohad Aviezer
HUJI Team
Shahar Zachariah
TAU Lead
Anne Krinsky
TAU Team
Muhammad Abu Ahmad
BGU Lead
Amit Geva
BGU Team
Tal Manko
BGU Team
Shelly Gendler
BIU Lead
Sigal Graboys
BIU Team

BGU<br />MSc — Daniel Somekh
Managing Director & Dir., Programs - BGU
MSc

ITT<br />BSc — Yael Tahan
Managing Director & Dir., Partnerships - ITT
BSc

BIU<br />PhD — Sarit Feldman
Dir., Communities - BIU
PhD

BIU<br />PhD — Ron Nagar
Dir., Finance - BIU
PhD

HUJI<br />PhD — Shalhevet Klemfner
HUJI Lead - HUJI
PhD

HUJI<br />PhD — Elisheva Gur
HUJI Team - HUJI
PhD

HUJI<br />PhD — Naomi Tawil-Winter
HUJI Team - HUJI
PhD

HUJI<br />PhD — Elad Dvir
HUJI Team - HUJI
PhD

HUJI<br />BSc & MBA — Ohad Aviezer
HUJI Team - HUJI
BSc & MBA

TAU<br />PhD — Shahar Zachariah
TAU Lead - TAU
PhD

TAU<br />MD student — Anne Krinsky
TAU Team - TAU
MD student

BGU<br />PhD — Muhammad Abu Ahmad
BGU Lead - BGU
PhD

BGU<br />MSc — Amit Geva
BGU Team - BGU
MSc

BGU<br />PhD — Tal Manko
BGU Team - BGU
PhD

BIU<br />PhD — Shelly Gendler
BIU Lead - BIU
PhD

BIU<br />MSc — Sigal Graboys
BIU Team - BIU
MSc

Apply for
Activator

2024 COHORT

Nucleate's Activator forms pioneering biotech companies without taking equity.
Timeline and FAQ.

Deadline for US chapters is October 21st. Deadline for international chapters will vary. Please contact your local chapter to verify.

REQUIREMENTS

01

Approval from PI
02

Well defined technology / product backed by preliminary scientific research (Therapeutic modalities - Platform technologies - Diagnostics - Medical Devices)
03

Existing IP to protect the technology, or clear path to file IP within the next year
04

Clear potential to apply the technology
05

Team intending and willing to 'spin-out' in the near future